Cargando…

Pembrolizumab-Induced Severe Neuropathy in a Patient with Metastatic Urothelial Carcinoma after Achieving Complete Response: Guillain-Barré Syndrome-Like Onset

An 85-year-old female was admitted to our hospital for left ureteral cancer and para-aortic lymph node metastasis. To control hematuria, a laparoscopic retroperitoneal nephroureterectomy was performed, and papillary urothelial carcinoma (pT3b) was found. To treat para-aortic lymph node metastasis, s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Aoki, Shuntaro, Yasui, Masato, Tajirika, Hironao, Terao, Hideyuki, Funahashi, Makoto, Ohta, Junichi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	S. Karger AG 2020
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7841730/ https://www.ncbi.nlm.nih.gov/pubmed/33564288 http://dx.doi.org/10.1159/000511567

Ejemplares similares

Localized amyloidosis of the ureter: a case report
por: Aoki, Shuntaro, et al.
Publicado: (2023)

Pembrolizumab: Guillain Barre Syndrome: case report
Publicado: (2021)

Guillain-Barre syndrome induced by pembrolizumab and sunitinib: A case report
por: Han, Chen, et al.
Publicado: (2020)

Acute Toxic Neuropathy Mimicking Guillain Barre Syndrome
por: Jalal, Muhammed Jasim Abdul, et al.
Publicado: (2015)

A Case of Diabetic Neuropathy Combined with Guillain-Barre Syndrome
por: Jin, Heung-Yong, et al.
Publicado: (2010)

Multiple Cranial Neuropathies Without Limb Involvements: Guillain-Barre Syndrome Variant?
por: Yu, Ju Young, et al.
Publicado: (2013)

Prognostic model for time to achieve independent walking in children with Guillain-Barré syndrome
por: Chaweekulrat, Peerada, et al.
Publicado: (2022)

Guillain–Barré syndrome
por: Mirian, Ario, et al.
Publicado: (2021)

Profile of pembrolizumab in the treatment of patients with unresectable or metastatic urothelial carcinoma
por: Inokuchi, Junichi, et al.
Publicado: (2019)

Safe Transition to Pembrolizumab following Ipilimumab-Induced Guillain-Barré Syndrome: A Case Report and Review of the Literature
por: Gravbrot, Nicholas, et al.
Publicado: (2019)

A study of Guillain–Barré syndrome with reference to cranial neuropathy and its prognostic implication
por: Bhargava, Amita, et al.
Publicado: (2014)

Acute Fulminant Uremic Neuropathy Following Coronary Angiography Mimicking Guillain–Barre Syndrome
por: Priti, Kumari, et al.
Publicado: (2017)

Safe Administration of Ipilimumab, Pembrolizumab, and Nivolumab in a Patient with Metastatic Melanoma, Psoriasis, and a Previous Guillain–Barré Syndrome
por: Cortellini, Alessio, et al.
Publicado: (2018)

A Case of Guillain-Barré Syndrome and Stevens-Johnson Syndrome/Toxic Epidermal Necrosis Overlap After Pembrolizumab Treatment
por: Oguri, Tomoyo, et al.
Publicado: (2021)

Pembrolizumab related Guillain barre syndrome, a rare presentation in a patient with a history of lupus and bladder cancer
por: Sangani, Vikram, et al.
Publicado: (2021)

Probiotics as a Potential Alternative for Relieving Peripheral Neuropathies: a Case for Guillain-Barré Syndrome
por: Saxena, Abhishek
Publicado: (2016)

Acute beriberi neuropathy mimicking Guillain-Barré syndrome after a strict vegetarian diet
por: Riahi, Anis, et al.
Publicado: (2017)

Hereditary neuropathy with liability to pressure palsies misdiagnosed as Guillain–Barré Syndrome: A case report
por: Zhu, Jianming, et al.
Publicado: (2022)

The acute motor axonal neuropathy variant of Guillain–Barré Syndrome diagnosed after ankle trauma
por: Erdurmus, Omer Yusuf, et al.
Publicado: (2022)

Hyperreflexic Guillain-Barré syndrome
por: Baheti, Neeraj N., et al.
Publicado: (2010)

An Update in Guillain-Barré Syndrome
por: Winer, J. B.
Publicado: (2014)

Guillain–Barré syndrome mimics
por: Tham, Sai Leong, et al.
Publicado: (2018)

Syndrome de Guillain–Barré
por: Mirian, Ario, et al.
Publicado: (2021)

Complete response to pembrolizumab in recurrent nested variant of urothelial carcinoma
por: Fukuta, Kyotaro, et al.
Publicado: (2021)

Treatment Considerations for Patients with Unresectable Metastatic Melanoma Who Develop Pembrolizumab-Induced Guillain-Barré Toxicity: A Case Report
por: Muralikrishnan, Sivraj, et al.
Publicado: (2020)

SARS-CoV-2-Associated Guillain-Barre Syndrome Obscured by Diabetes Mellitus Peripheral Neuropathy
por: Brown, Miranda, et al.
Publicado: (2021)

Post COVID-19 Guillain–Barre syndrome presents as sensory dominant neuropathy with reversible conduction failure
por: AlTahan, Abdulrahman M., et al.
Publicado: (2023)

COVID-19: a modern trigger for Guillain-Barre syndrome, myasthenia gravis, and small fiber neuropathy
por: Gomez, Francisco, et al.
Publicado: (2023)

Vision Loss in Guillain-Barre Syndrome: Is it a Complication of Guillain-Barre Syndrome or Just a Coincidence?
por: Ramakrishnan, Sri, et al.
Publicado: (2016)

Sídrome de Guillain-Barré : aspectos terapéuticos
por: Abad Alfonso, Fernando
Publicado: (1998)

Treatment guidelines for Guillain–Barré Syndrome
por: Meena, A. K., et al.
Publicado: (2011)

Atypical Guillain-Barré in the Emergency Department
por: Sheridan, Josh M., et al.
Publicado: (2010)

Brucellosis, Presenting with Guillain-Barré Syndrome
por: Babamahmoodi, Farhang, et al.
Publicado: (2011)

Guillain-Barre syndrome and mood disorders
por: Neroutsos, Evangelos, et al.
Publicado: (2010)

Syringomyelia Coexisting With Guillain-Barre Syndrome
por: Kim, Hee-Sang, et al.
Publicado: (2013)

Fulminant Guillain-Barré Syndrome with Myocarditis
por: Mishra, Ajay, et al.
Publicado: (2014)

Prognosis of Guillain-Barré Syndrome in Children
por: SALEHIOMRAN, Mohammad Reza, et al.
Publicado: (2016)

Outbreak of Guillain-Barre syndrome in Peru
por: Díaz-Soto, S., et al.
Publicado: (2019)

Guillain-Barré syndrome in times of pandemics
por: Leonhard, Sonja E, et al.
Publicado: (2020)

COVID-19 and Guillain-Barré syndrome
por: Joob, B., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_415qsrfgbsltglpvvvjjkb577n